WallStreetZenWallStreetZen

NASDAQ: ELYM
Eliem Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ELYM stock forecasts and price targets.

Forecast return on equity

Is ELYM forecast to generate an efficient return?
Company
N/A
Industry
-46.09%
Market
21.34%

Forecast return on assets

Is ELYM forecast to generate an efficient return on assets?
Company
N/A
Industry
4.45%

ELYM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ELYM$2.76N/AN/A
CDTX$0.84$6.00+612.59%Buy
ONCY$1.03$5.00+385.44%Buy
KRON$1.24$4.25+242.74%Strong Buy
ALGS$0.98N/AN/A

Eliem Therapeutics Stock Forecast FAQ

What is ELYM's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: ELYM) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Eliem Therapeutics stock.

What is ELYM's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: ELYM) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 4.45%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.